Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain A M MacPhee

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 21, 2013
Renohepatic crosstalk: does acute kidney injury cause liver dysfunction?Katie Lane, John J Dixon, Iain A M MacPhee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 15, 2009
Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groupsFu Liang Ng, David W Holt, Rene W S Chang, et al.
British Journal of Clinical Pharmacology|January 12, 2013
A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipientsOliver Boughton, Gabor Borgulya, Maurizio Cecconi, et al.
Iranian Journal of Kidney Diseases|September 28, 2013
Acute page kidney complicating kidney transplant artery stenting: presentation of a case and novel managementAlireza Hamidian Jahromi, Jiri Fronek, Nicos Kessaris, et al.
Intensive Care Medicine|February 10, 2009
Using midazolam to monitor changes in hepatic drug metabolism in critically ill patientsChristopher John Kirwan, Terry Lee, David W Holt, et al.
BMC Nephrology|March 13, 2020
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipientsMysore K Phanish, Richard P Hull, Peter A Andrews, et al.
Transplantation|September 14, 2006
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirementsSalim Fredericks, Michelle Moreton, Sandrine Reboux, et al.
Journal of Proteomics|May 28, 2014
HSP70, Peroxiredoxin-3 and -6 are upregulated during renal warm ischaemia in a donation after circulatory death modelMohammad A Hossain, Ayesha I De Souza, Atul Bagul, et al.
Journal of Translational Medicine|April 18, 2015
Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trialJohn J Dixon, Katie Lane, R Neil Dalton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantationIain A M MacPhee, Salim Fredericks, Tracy Tai, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 21, 2013
Renohepatic crosstalk: does acute kidney injury cause liver dysfunction?Katie Lane, John J Dixon, Iain A M MacPhee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 15, 2009
Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groupsFu Liang Ng, David W Holt, Rene W S Chang, et al.
British Journal of Clinical Pharmacology|January 12, 2013
A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipientsOliver Boughton, Gabor Borgulya, Maurizio Cecconi, et al.
Iranian Journal of Kidney Diseases|September 28, 2013
Acute page kidney complicating kidney transplant artery stenting: presentation of a case and novel managementAlireza Hamidian Jahromi, Jiri Fronek, Nicos Kessaris, et al.
Intensive Care Medicine|February 10, 2009
Using midazolam to monitor changes in hepatic drug metabolism in critically ill patientsChristopher John Kirwan, Terry Lee, David W Holt, et al.
BMC Nephrology|March 13, 2020
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipientsMysore K Phanish, Richard P Hull, Peter A Andrews, et al.
Transplantation|September 14, 2006
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirementsSalim Fredericks, Michelle Moreton, Sandrine Reboux, et al.
Journal of Proteomics|May 28, 2014
HSP70, Peroxiredoxin-3 and -6 are upregulated during renal warm ischaemia in a donation after circulatory death modelMohammad A Hossain, Ayesha I De Souza, Atul Bagul, et al.
Journal of Translational Medicine|April 18, 2015
Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trialJohn J Dixon, Katie Lane, R Neil Dalton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantationIain A M MacPhee, Salim Fredericks, Tracy Tai, et al.
Pageof 3